Galapagos NV Current Ratio 2011-2026 | GLPG

Annual Current Ratio Galapagos NV

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.34	2.79	2.14	2.04	1.88	1.9	6.39	4.69	9.7	5.17	3.54	1.57	1.22	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
9.7	1.22	3.57

Quarterly Current Ratio Galapagos NV

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	2.04	-	1.96	-	1.88	-	1.9	-	1.9	-	6.33	-	6.39	-	3.78	-	4.69	-	-	-	3.34	-	-	-	5.71	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
6.39	1.88	3.63

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	28.7	-	1052.0 %	$ 415 M	USA
Amphastar Pharmaceuticals AMPH	1.94	$ 19.55	0.1 %	$ 914 M	USA
Aeterna Zentaris AEZS	1.6	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	6.48	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	2.39	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	3.34	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	2.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	10.8	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	3.27	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	6.43	-	-	$ 7.46 M	Israel
Atreca BCEL	2.02	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	1.61	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	1.46	-	-	$ 546 M	USA
Acasti Pharma ACST	13.4	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Avid Bioservices CDMO	1.22	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	1.65	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	0.41	-	2.71 %	$ 14 M	USA
Advaxis ADXS	5.93	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	2.2	$ 1.2	-6.98 %	$ 306 M	Britain
BeiGene, Ltd. BGNE	2.14	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	2.37	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	1.83	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.05	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	6.76	$ 1.07	-1.83 %	$ 21.9 M	Israel
Enochian Biosciences ENOB	0.278	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
Equillium EQ	9.69	$ 2.02	-1.94 %	$ 116 M	USA
Eton Pharmaceuticals ETON	1.4	$ 23.73	1.17 %	$ 639 M	USA
Bellerophon Therapeutics BLPH	1.47	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	6.6	$ 46.34	-2.54 %	$ 4.17 B	Schweiz
Arbutus Biopharma Corporation ABUS	5.24	$ 4.44	-0.22 %	$ 851 M	Canada
Allakos ALLK	3.26	-	-	$ 28.6 M	USA
Brickell Biotech BBI	5.28	-	-5.38 %	$ 6.06 M	USA
Freeline Therapeutics Holdings plc FRLN	2.53	-	-	$ 384 M	Britain
Allena Pharmaceuticals ALNA	2.19	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	4.13	-	-10.95 %	$ 876 K	USA
Fusion Pharmaceuticals FUSN	4.51	-	-	$ 1.41 B	Canada